Sign up for Breaking News Email Alerts

About Cell Therapy Pharmaceuticals ShareThis Contact Us


Press Releases

Archives: Search / 2016 / 2015 / 2014 / 2013 / 2012

201120102009200820072006

2010 Archives

12/16/2010
Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
11/17/2010
Neuralstem Files FDA Application for First Drug Therapy NSI-189 for the Treatment of Major Depression
11/16/2010
Neuralstem Reports Third Quarter Financial Results and Provides Business and Clinical Update
11/02/2010
Neuralstem Awarded Three Federal Grants
Funds Will Advance Multiple Programs
10/18/2010
Neuralstem Updates ALS Clinical Trial Progress
Approved to Dose Early-Stage Patients
09/30/2010
Neuralstem Chairman and Chief Scientific Officer to Take Part in World Stem Cell Summit Plenary Session
09/14/2010
Neuralstem Stem Cells Survive and Differentiate Into Neurons in Rats With Stroke
IMPROVED MOTOR FUNCTION OBSERVED
09/07/2010
Neuralstem Collaborator to Present Stroke Study Results at Stem Cell & Regenerative Medicine Conference
08/25/2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
08/18/2010
Neuralstem Receives Confirmation of Patent Claims From United States Patent and Trademark Office
08/16/2010
Neuralstem Reports Second Quarter Financial Results and Provides Business & Clinical Update
06/30/2010
Neuralstem Completes $10 Million Registered Direct Offering
Financing Solidifies Clinical Platform Into 2012
06/25/2010
Neuralstem to Raise $10 Million in Registered Direct Offering
06/04/2010
Neuralstem ALS Trial Principal Investigator To Speak At Brookings Institution
05/24/2010
Neuralstem Updates Clinical Trial Progress
05/17/2010
Neuralstem, Inc. Reports First Quarter Financial Results and Provides Business Update
05/10/2010
Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
05/04/2010
CNN.com Health Features Neuralstem's Stem Cell Treatment
04/30/2010
Neuralstem's ALS Stem Cell Treatment Featured on CNN
03/31/2010
Neuralstem Announces 2009 Financial Results, Provides Update
02/18/2010
Neuralstem Completes $5.25 Million Financing
Received NYSE AMEX Notice of Compliance
01/21/2010
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
 

print rss

Privacy and Terms ©Neuralstem, Inc. 2016

Information for Investors

ShareThis Copy and Paste